D3 Bio Investigative Site

Chengdu, Sichuan 610041

1 studies enrolling now · 1 studies all time

What they study most

Advanced Solid Tumors With MAPK Pathway Mutations

Studies at this site

• A Phase 1/2 Study of D3S-002 as Monotherapy or Combination Therapy in Adult Subjects With Advanced Solid Tumors With MAPK Pathway Mutations — Recruiting now